文献速递心力衰竭与心肌病

Dusp14介导MLKL去磷酸化抑制甲状腺功能减退诱导的心肌细胞坏死性凋亡

Dusp14-Mediated Dephosphorylation of MLKL Protects Against Cardiomyocyte Necroptosis in Hypothyroidism-Induced Heart Failure.
PubMed 文献 · Circulation · 2025-05-13

本研究通过丙硫氧嘧啶建立小鼠甲状腺功能减退(甲减)诱导的心力衰竭模型,发现心肌坏死性凋亡激活,Dusp14通过抑制坏死性凋亡减轻甲减诱导的心力衰竭,并鉴定小分子化合物P077-0472为Dusp14激活剂,可抑制甲减心肌细胞坏死性凋亡,提供潜在治疗途径。

要点

  • 甲减诱导的心力衰竭小鼠心肌坏死性凋亡激活,表现为MLKL磷酸化水平升高。
  • 心肌特异性过表达Dusp14减少坏死性凋亡并改善收缩功能,而Dusp14敲除加重损伤。
  • 小分子化合物P077-0472激活Dusp14去磷酸化功能,抑制甲减心肌细胞坏死性凋亡。

核心结论

  • Dusp14通过抑制甲状腺功能减退诱导的心肌细胞坏死性凋亡,挽救受损心肌细胞,改善心力衰竭。
  • P077-0472作为Dusp14激活剂,可抑制甲状腺功能减退诱导的心肌细胞坏死性凋亡。

研究设计与样本

  • 通过丙硫氧嘧啶给药建立小鼠甲状腺功能减退诱导的心力衰竭模型。
  • 使用Dusp14敲除小鼠和腺相关病毒介导的心肌细胞特异性Dusp14过表达,结合细胞实验。
  • 通过分子对接鉴定调节Dusp14活性的小分子化合物。

主要发现

  • 甲减组小鼠心肌组织切片显示伊文思蓝染色阳性,血清心肌损伤标志物乳酸脱氢酶水平较甲状腺功能正常组显著升高(n=8)。
  • 甲减组心肌坏死性凋亡标志物MLKL磷酸化水平显著升高(n=8)。
  • 心肌特异性过表达Dusp14减少甲减小鼠心肌坏死性凋亡并改善心肌收缩功能(n=8)。
  • Dusp14敲除加重甲减小鼠心肌收缩功能障碍和坏死性凋亡(n=5-7)。
  • 小分子化合物P077-0472被鉴定为Dusp14激活剂,可抑制甲减心肌细胞坏死性凋亡(n=6)。

关键数值与推荐

  • 甲减组小鼠血清乳酸脱氢酶水平显著高于甲状腺功能正常组(n=8)。
  • 甲减组心肌MLKL磷酸化水平显著升高(n=8)。
  • Dusp14过表达组(n=8)和敲除组(n=5-7)分别显示坏死性凋亡减少和加重。
  • P077-0472处理组(n=6)显示抑制甲减心肌细胞坏死性凋亡。

临床怎么用

  • Dusp14可能是甲状腺功能减退诱导的心力衰竭的潜在治疗靶点。
  • P077-0472作为Dusp14激活剂,为甲减相关心力衰竭提供候选药物,但需进一步临床验证。

局限性

  • 研究仅基于小鼠模型和细胞实验,尚未在人体中验证。
  • P077-0472的有效性和安全性需进一步药理学和临床研究评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hypothyroidism leads to multiple organ dysfunction, with the heart the most affected. However, the pathologic mechanism of hypothyroidism-induced heart failure remains to be completely elucidated. Thyroid hormone replacement therapy enhances myocardium systolic function but increases the occurrence of arrythmias. There is an urgent need to explore these mechanisms in detail and to discover and develop drugs that can target and manage heart failure in patients with hypothyroidism. METHODS: In this study, a mouse model of hypothyroidism-induced heart failure was established through the administration of propylthiouracil. Dusp14 knockout mice were generated, and adeno-associated virus-mediated cardiomyocyte-specific overexpression of Dusp14 (dual specificity phosphatase 14) was used in combination with related cellular experiments to investigate the protective effects of Dusp14 on hypothyroidism-induced heart failure. Further analyses confirmed the crucial involvement of necroptosis in the pathogenesis of hypothyroidism-induced heart failure, and demonstrated the protective role of Dusp14 in modulating necroptosis. In addition, a novel small molecule compound that effectively regulates Dusp14 activity in vitro was identified through molecular docking, providing a potential therapeutic avenue. RESULTS: Dusp14 regulates necroptosis and mitigates hypothyroidism-induced heart failure. Myocardial tissue sections from mice in the hypothyroidism group showed positive Evans blue dye staining, and the serum levels of the myocardial injury marker lactate dehydrogenase were significantly higher compared with the euthyroid group (n=8). In addition, phosphorylation levels of the necroptosis marker MLKL (mixed lineage kinase domain-like protein) were significantly elevated, indicating the activation of necroptosis (n=8). These findings suggest that myocardial necroptosis is activated during hypothyroidism. Myocardial-specific overexpression of Dusp14 reduced myocardial necroptosis and improved myocardial contractile function in hypothyroid mice (n=8). In contrast, Dusp14 knockout exacerbated myocardial contractile dysfunction and necroptosis in these mice (n=5-7). These results indicate that Dusp14 alleviates hypothyroidism-induced heart failure by inhibiting necroptosis. P077-0472, a small molecule compound, was identified as an activator of Dusp14, which could inhibit cardiomyocyte necroptosis from hypothyroidism (n=6). CONCLUSIONS: Dusp14 inhibits cardiomyocyte necroptosis from hypothyroidism and consequently rescues damaged cardiomyocytes. P077-0472, a novel small molecule compound that activates the dephosphorylation function of Dusp14, could inhibit cardiomyocyte necroptosis from hypothyroidism.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Zheng, Cao, Wang, et al. Dusp14-Mediated Dephosphorylation of MLKL Protects Against Cardiomyocyte Necroptosis in Hypothyroidism-Induced Heart Failure. Circulation. 2025. PMID: 40357546. doi:10.1161/CIRCULATIONAHA.125.074353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。